Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.10.2023 | Case report

Multiple drugs

Pulmonary mucormycosis (Lichtheimia spp ) following off-label use and lack of efficacy during pregnancy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Hanks J, et al. Successful treatment of pulmonary mucormycosis (Lichtheimia spp.) in a post-partum patient with COVID-19 ARDS requiring extra-corporeal membrane oxygenation using salvage therapy. Perfusion (London) 38: 1315-1318, No. 6, Sep 2023. Available from: URL: https://journals.sagepub.com/home/PRF Hanks J, et al. Successful treatment of pulmonary mucormycosis (Lichtheimia spp.) in a post-partum patient with COVID-19 ARDS requiring extra-corporeal membrane oxygenation using salvage therapy. Perfusion (London) 38: 1315-1318, No. 6, Sep 2023. Available from: URL: https://​journals.​sagepub.​com/​home/​PRF
Metadaten
Titel
Multiple drugs
Pulmonary mucormycosis (Lichtheimia spp ) following off-label use and lack of efficacy during pregnancy: case report
Publikationsdatum
01.10.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-48053-6

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Guselkumab

Case report

Oseltamivir

Case report

Paliperidone

Case report

Sintilimab